Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
NatWest Group $750 million Additional Tier 1 capital notes offering
We advised NatWest Group on the SEC-registered offering of contingent convertible notes
Sprinklr $254 million IPO
We advised the underwriters on the IPO and NYSE listing
51job, Inc. going-private transaction
We are advising the special committee of the board of directors of 51job in connection with its going-private acquisition
Clarivate $2 billion senior secured notes and senior notes offering
We advised Clarivate on the high-yield debt offering in connection with its previously announced acquisition of ProQuest
Energizer Gamma Acquisition €650 million notes offering
We advised the initial purchasers on the high-yield notes offering
Focus Financial Partners $373 million follow-on offering
We advised the underwriter on the equity offering
Summit Healthcare Acquisition $200 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Washington Prime Group chapter 11 filing
We are advising SVPGlobal and its affiliated funds as plan sponsor in connection with the restructuring
Century Therapeutics $242.7 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Cyteir Therapeutics $133.2 million IPO
We advised the underwriters on the IPO and Nasdaq listing